Skip to main content
Home
Center for Technology Transfer & Commercialization
  • Home
  • About
  • Inventors
  • Industry
  • Startup Support
  • News & Events
  • Contact Us
  • Quick Links

Search form

    Stephen Fesik
    • Facebook icon
    • Twitter icon
    • LinkedIn icon
    • YouTube icon

    Displaying 1 - 3 of 3


    Vanderbilt-discovered cancer killing compound is now available through Boehringer Ingelheim open science portal opnMe

    Researchers in the lab of Stephen Fesik, Orrin H.


    • Read more about Vanderbilt-discovered cancer killing compound is now available through Boehringer Ingelheim open science portal opnMe
    Related Categories: 
    Alex Waterson Biochemistry Boehringer Ingelheim cancer Department of Energy KRAS Lustgarten Foundation National Institutes of Health opnMe School of Medicine Basic Sciences Stephen Fesik Vanderbilt Institute for Chemical Biology

    Cancer’s SOS

    Cancer’s SOS - New Research From Stephen Fesik and Colleagues


    • Read more about Cancer’s SOS
    Related Categories: 
    Research ACS Chemical Biology Basic Sciences Drug Discovery department of biochemistry Department of Chemistry Department of Pharmacology g protein Lustgarten Foundation Stephen Fesik

    Boehringer Ingelheim and Vanderbilt University expand partnership to develop novel treatment approaches for cancer

    Boehringer Ingelheim & Vanderbilt University expand partnership to develop novel treatment approaches for cancer


    • Read more about Boehringer Ingelheim and Vanderbilt University expand partnership to develop novel treatment approaches for cancer
    Related Categories: 
    Stephen Fesik Boehringer Ingelheim cancer MCL1
    Center for Technology Transfer & Commercialization
    2100 West End Ave, Suite 750
    Nashville, TN 37203
    Tel: 615.343.2430
     
    © 2014 -2025 Vanderbilt University
    Send message